Decipher Labs Ltd Share Price & Stock Analysis

Decipher Labs Ltd (BSE: 524752) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹6 Cr, it ranks #4,969 by market cap among the 6,197 Indian listed companies on FinBizNet, and #82 of 86 in Medicinal Chemicals and Botanical Products. At ₹5.67 (as of 16 Nov 2026), the share price is 48.4% below its 52-week high of ₹10.99 and 17.9% above its 52-week low of ₹4.81. The share price is down 42.2% over one year and down 10.6% over three months.

Key Metrics

Current Price₹5.67
Market Cap₹6 Cr
BSE Code524752
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E RatioNot meaningful (loss)
Return on Equity-14.17%
Return on Assets-8.74%
52-Week Range₹4.81 – ₹10.99
1-Year Price Change-42.2%
3-Month Price Change-10.6%
Beta (1Y)0.82
HeadquartersHyderabad, Telangana
Websitedecipherlabs.in

Shareholding and Delivery

Delivery averaged 91.6% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Decipher Labs Ltd

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through Pharmaceutical and Consultancy segments. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.

Products and Services

1. Manufacturing and Trading of Pharmaceutical Drugs-This segment engages in the manufacture, sale, and export of pharmaceutical formulations and customized non-sterile products in India. Its product line comprises tablets, capsules, ointments, and liquid orals. 2. Consultancy Services-This segment provides consultancy services. 3. Segment Adjustment-0

Business Segments

1. Pharma-4.8% 2. Consultancy Services-95.2%

Decipher Labs Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Decipher Labs Ltd₹6 Crn/m-14.17%—-42.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Decipher Labs Ltd?

Decipher Labs Ltd is trading at ₹5.67, with a market capitalisation of ₹6 Cr.

Which sector does Decipher Labs Ltd belong to?

Decipher Labs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Decipher Labs Ltd?

Decipher Labs Ltd has a return on equity of -14.17%.

What is the stock symbol of Decipher Labs Ltd?

Decipher Labs Ltd is listed on the BSE under the scrip code 524752.

How has Decipher Labs Ltd's share price moved over the past year?

Decipher Labs Ltd's share price is down 42.2% over one year and down 10.6% over three months. Its 52-week range is ₹4.81 to ₹10.99.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.